161 related articles for article (PubMed ID: 11579680)
1. Somatostatin type 2A receptor immunoreactivity in human pancreatic adenocarcinomas.
Pilichowska M; Kimura N; Schindler M; Kobari M
Endocr Pathol; 2001; 12(2):147-55. PubMed ID: 11579680
[TBL] [Abstract][Full Text] [Related]
2. Mixed ductal-endocrine carcinomas of the pancreas and ductal adenocarcinomas with scattered endocrine cells: characterization of the endocrine cells.
Ohike N; Jürgensen A; Pipeleers-Marichal M; Klöppel G
Virchows Arch; 2003 Mar; 442(3):258-65. PubMed ID: 12647216
[TBL] [Abstract][Full Text] [Related]
3. Progesterone receptor immunoreactivity in pancreatic endocrine tumors. An immunocytochemical study of 156 neuroendocrine tumors of the pancreas, gastrointestinal and respiratory tracts, and skin.
Viale G; Doglioni C; Gambacorta M; Zamboni G; Coggi G; Bordi C
Cancer; 1992 Nov; 70(9):2268-77. PubMed ID: 1356613
[TBL] [Abstract][Full Text] [Related]
4. Chromogranin A plasma concentration and expression in pancreatic islet cell tumors of dogs and cats.
Myers NC; Andrews GA; Chard-Bergstrom C
Am J Vet Res; 1997 Jun; 58(6):615-20. PubMed ID: 9185968
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical localization of somatostatin receptor type 2A in rat and human tissues.
Kimura N; Schindler M; Kasai N; Kimura I
Endocr J; 2001 Feb; 48(1):95-102. PubMed ID: 11403108
[TBL] [Abstract][Full Text] [Related]
6. Chromostatin, a chromogranin A-derived bioactive peptide, is present in human pancreatic insulin (beta) cells.
Cetin Y; Aunis D; Bader MF; Galindo E; Jörns A; Bargsten G; Grube D
Proc Natl Acad Sci U S A; 1993 Mar; 90(6):2360-4. PubMed ID: 8096340
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemistry of pancreatic islet cell tumors in the ferret (Mustela putorius furo).
Andrews GA; Myers NC; Chard-Bergstrom C
Vet Pathol; 1997 Sep; 34(5):387-93. PubMed ID: 9381649
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological value of somatostatin type 2A and estrogen receptor immunoreactivity in human breast carcinoma.
Pilichowska M; Kimura N; Suzuki A; Yoshida R; Schindler M; Nagura H
Endocr Pathol; 2001; 12(1):55-61. PubMed ID: 11478269
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical expression of somatostatin type 2A receptor in neuroendocrine carcinoma of uterine cervix.
Kajiwara H; Hirabayashi K; Miyazawa M; Nakamura N; Hirasawa T; Muramatsu T; Mikami M; Yasuda M; Osamura RY
Arch Gynecol Obstet; 2009 Apr; 279(4):521-5. PubMed ID: 18726606
[TBL] [Abstract][Full Text] [Related]
10. Somatostatin receptor scintigraphy versus chromogranin A assay in the management of patients with neuroendocrine tumors of different types: clinical role.
Cimitan M; Buonadonna A; Cannizzaro R; Canzonieri V; Borsatti E; Ruffo R; De Apollonia L
Ann Oncol; 2003 Jul; 14(7):1135-41. PubMed ID: 12853358
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical study of endocrine cells in ductal adenocarcinoma of the pancreas.
Sakaki M; Sano T; Hirokawa M; Takahashi M; Kiyoku H
Virchows Arch; 2002 Sep; 441(3):249-55. PubMed ID: 12242521
[TBL] [Abstract][Full Text] [Related]
12. Neuroendocrine cells in pancreatic duct adenocarcinoma: an immunohistochemical study.
Linder S; Myrvold K; Falkmer UG; Qvigstad G; Waldum HL; Falkmer SE
J Exp Clin Cancer Res; 2006 Jun; 25(2):213-21. PubMed ID: 16918133
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical characterization of endocrine cells in experimental exocrine pancreatic cancer in the Syrian golden hamster.
Dawiskiba S; Pour PM; Stenram U; Sundler F; Andrén-Sandberg A
Int J Pancreatol; 1992 Apr; 11(2):87-96. PubMed ID: 1351511
[TBL] [Abstract][Full Text] [Related]
14. Endocrine cells in colorectal adenocarcinomas: incidence, hormone profile and prognostic relevance.
de Bruïne AP; Wiggers T; Beek C; Volovics A; von Meyenfeldt M; Arends JW; Bosman FT
Int J Cancer; 1993 Jul; 54(5):765-71. PubMed ID: 8100808
[TBL] [Abstract][Full Text] [Related]
15. Expression of chromogranin A and somatostatin receptors in pancreatic AR42J cells.
Hofsli E; Thommesen L; Nørsett K; Falkmer S; Syversen U; Sandvik A; Laegreid A
Mol Cell Endocrinol; 2002 Aug; 194(1-2):165-73. PubMed ID: 12242039
[TBL] [Abstract][Full Text] [Related]
16. Analysis of somatostatin receptor 2A immunohistochemistry, RT-qPCR, and in vivo PET/CT data in patients with pancreatic neuroendocrine neoplasm.
Kaemmerer D; Wirtz RM; Fischer EK; Hommann M; Sänger J; Prasad V; Specht E; Baum RP; Schulz S; Lupp A
Pancreas; 2015 May; 44(4):648-54. PubMed ID: 25872131
[TBL] [Abstract][Full Text] [Related]
17. Somatostatin analogue inhibits the mobility of prostate carcinoma cells: a new therapeutic method for advanced prostate carcinoma.
Tang X; Takekoshi S; Itoh J; Umemura S; Shoji S; Terachi T; Osamura RY
Int J Oncol; 2010 Nov; 37(5):1077-83. PubMed ID: 20878055
[TBL] [Abstract][Full Text] [Related]
18. Chromogranin-A expression in gastric and colon cancer tissues.
Park JG; Choe GY; Helman LJ; Gazdar AF; Yang HK; Kim JP; Park SH; Kim YI
Int J Cancer; 1992 May; 51(2):189-94. PubMed ID: 1349007
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical expression of somatostatin type 2A receptor in neuroendocrine tumors.
Kimura N; Pilichowska M; Date F; Kimura I; Schindler M
Clin Cancer Res; 1999 Nov; 5(11):3483-7. PubMed ID: 10589762
[TBL] [Abstract][Full Text] [Related]
20. Endocrine aspects of exocrine cancer of the pancreas. Their patterns and suggested biologic significance.
Pour PM; Permert J; Mogaki M; Fujii H; Kazakoff K
Am J Clin Pathol; 1993 Sep; 100(3):223-30. PubMed ID: 8379530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
